← Back to headlines
Eli Lilly to acquire Ajax Therapeutics for up to $2.3 billion
Pharmaceutical giant Eli Lilly is set to acquire Ajax Therapeutics in a deal potentially valued at up to $2.3 billion, expanding its therapeutic portfolio.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



